Petre Udrea
Neurology · Centerville, OHNPI 1245232024
Payments from drug & device makers
Across 197 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$571
- Novartis$473
- Biogen$428
- Amgen$349
- AbbVie$321
- Supernus Pharmaceuticals, Inc.$111
- plus $1K from 30 others
What the payments were for
- Food & beverage$3,557100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 25 | $571 |
| Novartis | 37 | $473 |
| Biogen | 11 | $428 |
| Amgen(2 entities) | 18 | $349 |
| AbbVie(2 entities) | 20 | $321 |
| Supernus Pharmaceuticals, Inc. | 6 | $111 |
| UCB, Inc. | 6 | $104 |
| Pfizer | 6 | $99 |
| Teva Pharmaceuticals USA, Inc. | 6 | $94 |
| Acadia Pharmaceuticals Inc | 6 | $84 |
| Sanofi | 4 | $82 |
| AstraZeneca(2 entities) | 4 | $69 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $68 |
| Acorda Therapeutics, Inc | 4 | $65 |
| SK Life Science, Inc. | 4 | $63 |
| Amneal Pharmaceuticals LLC | 3 | $62 |
| Genentech USA, Inc. | 3 | $58 |
| Biohaven Pharmaceuticals, Inc. | 3 | $43 |
| Octapharma USA, Inc. | 3 | $42 |
| Lilly USA, LLC | 3 | $41 |
| Neurocrine Biosciences, Inc. | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 2 | $39 |
| MDD US Operations, LLC | 2 | $32 |
| CSL Behring | 2 | $29 |
| Adamas Pharmaceuticals, Inc. | 2 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Neurelis, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Grifols USA, LLC | 1 | $13 |
| Greenwich Biosciences, Inc. | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| Portola Pharmaceuticals, LLC | 1 | $12 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TYSABRI$221
How this compares
$3,557 in reported general payments places this provider in the 55th percentile of 702 neurology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ropinirole Hcl | 13 | $173 |
Paid to pharmacies, not to this prescriber.
Other neurology in Centerville
- Kenneth PugarCenterville$1.9M
- Timothy SchoonoverCenterville$611K
- Derek MenkedickCenterville$425K
- Jon DurraniCenterville$413K
- Joel VandersluisDayton$12.3M
- Jerry MendellColumbus$11.5M
- Lawrence GoldstickDayton$6.9M
- Douglas ScharreColumbus$6.8M
- Robert BermelCleveland$6.4M
- Aaron BosterColumbus$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.